LBRY Block Explorer

LBRY Claims • SteveKirsch

1e86acede5736706c693cd75c5fa1ac52651a38a

Published By
Created On
18 Sep 2021 21:10:58 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
Treat Early - Fluvoxamine, Camostat, Selva SLV213, Doxazosin and Niclosamide | Steve Kirsch | Ep 39
Mirrored from: https://youtu.be/EZxrrMQZar8


Entrepreneur Steve Kirsch who holds an early patent for the optical mouse decided to get involved in treating Covid. Steve put in $1MM of his own money and raised $5MM in an effort to treat Covid in the early stages.

Time Stamps Below!

00:00 Intro
00:22 Welcoming Steve Kirsch
00:31 Optical Mouse invention
02:12 What was your goal when enrolled into MIT?
02:40 TreatEarly.org
05:47 Drug Repurposing
07:30 What Fluvoxamine is?
10:53 Is there any study on people taking Fluvoxamine?
12:34 Other SSRI
13:53 Why do government officials not advocate this treatment?
17:57 Do you have a medical team involved?
18:16 When this will end & how we get there? / How do you think this will end?
21:09 Have you reached out to Dr. Anthony Fauci?
21:50 George Fareed & Brian Tyson
24:00 Difference between engineer and medical professional (me and NIH)
26:36 Got vaccinated? Is it after TreatEarly.org?
28:24 Do you regret getting vaccinated?
31:48 Capitalize off of TreatEarly.org?
35:38 Got vaccinated and died
38:08 Autopsies point directly to vaccination
40:47 My calculations... nobody cares about the evidence
44:35 CDC won't listen
46:26 Don't engage in public debate
48:11 What do you think the purpose is?
51:12 There is going to be a record day of reckoning
52:57 Have reached out to Dr. Michael Baden?
53:19 Wrapping Up

https://www.treatearly.org

https://en.wikipedia.org/wiki/Steve_Kirsch

#treatearly
#covid
#fluvoxamine
Author
Content Type
Unspecified
video/mp4
Language
English
Open in LBRY

More from the publisher

VIDEO
TESTA
Controlling
VIDEO
MOON-
Controlling
VIDEO
HUR F
Controlling
VIDEO
PFIZE
Controlling
VIDEO
BLINK
Controlling
VIDEO
IRANS
Controlling
VIDEO
PREDI
Controlling
VIDEO
HOW Y
Controlling
VIDEO
MEDIA